{"id":"https://openalex.org/W2042912244","doi":"https://doi.org/10.1097/nrl.0b013e3181a968df","title":"Efficacy of Rivastigmine for Cognitive Symptoms in Parkinson Disease With Dementia","display_name":"Efficacy of Rivastigmine for Cognitive Symptoms in Parkinson Disease With Dementia","publication_year":2009,"publication_date":"2009-06-30","ids":{"openalex":"https://openalex.org/W2042912244","doi":"https://doi.org/10.1097/nrl.0b013e3181a968df","mag":"2042912244","pmid":"https://pubmed.ncbi.nlm.nih.gov/19590387"},"language":"en","primary_location":{"id":"doi:10.1097/nrl.0b013e3181a968df","doi":"https://doi.org/10.1097/nrl.0b013e3181a968df","is_oa":false,"landing_page_url":"https://doi.org/10.1097/nrl.0b013e3181a968df","pdf_url":null,"source":{"id":"https://openalex.org/S135892068","display_name":"The Neurologist","issn_l":"1074-7931","issn":["1074-7931","2331-2637"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Neurologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091802972","display_name":"Amy C. Almaraz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Amy C. Almaraz","raw_affiliation_strings":["Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038020557","display_name":"Erika D. Driver\u2010Dunckley","orcid":"https://orcid.org/0000-0003-3938-0648","observed_orcids":["https://orcid.org/0000-0003-3938-0648"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Erika D. Driver-Dunckley","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068423077","display_name":"Bryan Keith Woodruff","orcid":"https://orcid.org/0000-0002-4728-7294","observed_orcids":["https://orcid.org/0000-0002-4728-7294"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bryan K. Woodruff","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082395750","display_name":"Kay E. Wellik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kay E. Wellik","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]},{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074086871","display_name":"Richard J. Caselli","orcid":"https://orcid.org/0000-0001-5784-2987","observed_orcids":["https://orcid.org/0000-0001-5784-2987"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard J. Caselli","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034553945","display_name":"Bart M. Demaerschalk","orcid":"https://orcid.org/0000-0001-7262-817X","observed_orcids":["https://orcid.org/0000-0001-7262-817X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bart M. Demaerschalk","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024500161","display_name":"Charles H. Adler","orcid":"https://orcid.org/0000-0002-1045-2743","observed_orcids":["https://orcid.org/0000-0002-1045-2743"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Charles H. Adler","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110665899","display_name":"John N. Caviness","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John N. Caviness","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008002660","display_name":"Dean M. Wingerchuk","orcid":"https://orcid.org/0000-0003-1608-8206","observed_orcids":["https://orcid.org/0000-0003-1608-8206"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dean M. Wingerchuk","raw_affiliation_strings":["the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Departments of *Neurology and \u2020Library Services and the Division of Education Administration, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5008002660","https://openalex.org/A5024500161","https://openalex.org/A5034553945","https://openalex.org/A5038020557","https://openalex.org/A5068423077","https://openalex.org/A5074086871","https://openalex.org/A5091802972","https://openalex.org/A5110665899"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"],"apc_list":null,"apc_paid":null,"fwci":1.0211,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.77598657,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"15","issue":"4","first_page":"234","last_page":"237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.5741999745368958,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.5741999745368958,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.3091000020503998,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0997999981045723,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.996999979019165},{"id":"https://openalex.org/keywords/parkinson-s-disease-dementia","display_name":"Parkinson's disease dementia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.9380000233650208},{"id":"https://openalex.org/keywords/acetylcholine","display_name":"acetylcholine","score":0.9419999718666077},{"id":"https://openalex.org/keywords/parkinsonism","display_name":"parkinsonism","score":0.6389999985694885},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6240000128746033},{"id":"https://openalex.org/keywords/number-needed-to-treat","display_name":"number needed to treat","score":0.6520000100135803},{"id":"https://openalex.org/keywords/number-needed-to-harm","display_name":"number needed to harm","score":0.8820000290870667},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.8849403858184814},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7785167694091797},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.6179623603820801},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.48583170771598816},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.4857226014137268},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.4666194021701813},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4614594578742981},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46083101630210876},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.43486860394477844},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3807261288166046},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.37486982345581055},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3428518772125244},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.341085284948349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3240475654602051},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09064927697181702},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/nrl.0b013e3181a968df","doi":"https://doi.org/10.1097/nrl.0b013e3181a968df","is_oa":false,"landing_page_url":"https://doi.org/10.1097/nrl.0b013e3181a968df","pdf_url":null,"source":{"id":"https://openalex.org/S135892068","display_name":"The Neurologist","issn_l":"1074-7931","issn":["1074-7931","2331-2637"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Neurologist","raw_type":"journal-article"},{"id":"pmid:19590387","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19590387","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The neurologist","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1164896577","https://openalex.org/W1472735294","https://openalex.org/W1953027527","https://openalex.org/W1985118959","https://openalex.org/W2035343397","https://openalex.org/W2077633683","https://openalex.org/W2112765817","https://openalex.org/W2115455636","https://openalex.org/W2132881915","https://openalex.org/W2147637063","https://openalex.org/W2151885529","https://openalex.org/W2167431281","https://openalex.org/W2188679450"],"related_works":["https://openalex.org/W2115455636","https://openalex.org/W2098447257","https://openalex.org/W1846919794","https://openalex.org/W2026372595","https://openalex.org/W2099549655","https://openalex.org/W1587341957","https://openalex.org/W2597741157","https://openalex.org/W2062029914","https://openalex.org/W2062367843","https://openalex.org/W3197234776"],"abstract_inverted_index":{"BACKGROUND:":[0],"Impairment":[1],"of":[2,42,53,71,157,198,212,274,283],"multiple":[3],"neurotransmitter":[4],"networks,":[5],"including":[6,149],"acetylcholine,":[7],"may":[8,276],"contribute":[9],"to":[10,161,185,190,193,227,252],"the":[11,32,66,69,105,113,150,209],"cognitive":[12,27,54,144],"impairment":[13],"in":[14,29,147,266],"patients":[15],"with":[16,19,61,96,132,263],"Parkinson":[17],"disease":[18,152],"dementia":[20],"(PDD).":[21],"Therefore,":[22],"cholinesterase":[23,49],"inhibitors":[24,50],"might":[25],"improve":[26,51],"function":[28,37],"PDD.":[30,62],"On":[31],"other":[33],"hand,":[34],"enhancing":[35],"cholinergic":[36,230],"could":[38],"plausibly":[39],"worsen":[40],"features":[41],"parkinsonism.":[43],"OBJECTIVE:":[44],"To":[45],"determine":[46],"if":[47],"oral":[48],"measures":[52],"outcome":[55,145,171,211],"and":[56,79,87,90,117,242,268],"are":[57],"tolerated":[58],"by":[59],"people":[60],"METHODS:":[63],"We":[64],"addressed":[65],"question":[67],"through":[68],"development":[70],"a":[72,84,97,109,281],"critically":[73],"appraised":[74],"topic.":[75],"Participants":[76,94],"included":[77],"consultant":[78],"resident":[80],"neurologists,":[81],"clinical":[82,99],"epidemiologists,":[83],"medical":[85],"librarian,":[86],"behavioral":[88],"neurology":[89],"movement":[91],"disorder":[92],"specialists.":[93],"began":[95],"structured":[98],"question,":[100],"devised":[101],"search":[102],"strategies,":[103],"compiled":[104],"best":[106],"evidence,":[107,114],"performed":[108],"critical":[110],"appraisal,":[111],"summarized":[112],"provided":[115],"commentary,":[116],"declared":[118],"bottom-line":[119],"conclusions.":[120],"RESULTS:":[121],"A":[122],"randomized":[123],"controlled":[124],"trial":[125],"(n":[126],"=":[127,177,183,204,237,246],"541)":[128],"showed":[129],"that,":[130],"compared":[131],"placebo,":[133],"rivastigmine":[134,249,275],"(mean,":[135],"8.6":[136],"mg/d)":[137],"significantly":[138],"improved":[139],"scores":[140],"on":[141],"2":[142],"coprimary":[143],"scales":[146],"PDD,":[148],"Alzheimer":[151],"Cooperative":[153],"Study-Clinician's":[154],"Global":[155],"Impression":[156],"Change.":[158],"When":[159],"dichotomized":[160],"evaluate":[162],"clinically":[163,195,215],"significant":[164,174,196,216,220,264],"benefit":[165,217],"(moderate":[166],"or":[167,218],"marked":[168],"improvement),":[169],"this":[170],"was":[172,200,222],"not":[173],"(risk":[175],"difference":[176],"5.3%;":[178],"95%":[179],"confidence":[180],"interval":[181],"(CI)":[182],"-1.6":[184],"12.1).":[186],"The":[187,206,224],"number":[188],"needed":[189,226],"treat":[191],"(NNT)":[192],"avoid":[194],"worsening":[197,221],"cognition":[199],"10":[201],"(95%":[202,235,244],"CI":[203,236,245],"6-28).":[205],"NNT":[207],"for":[208,229,239,248,259,280],"combined":[210],"either":[213],"achieving":[214],"avoiding":[219],"7.":[223],"numbers":[225],"harm":[228],"side":[231,254],"effects":[232],"were":[233],"9":[234],"5-24)":[238],"parkinsonian":[240],"symptoms":[241],"11":[243],"6-32)":[247],"discontinuation":[250],"due":[251],"any":[253],"effect.":[255],"CONCLUSION:":[256],"Rivastigmine":[257],"therapy":[258],"PDD":[260,284],"is":[261],"associated":[262],"tradeoffs":[265],"efficacy":[267],"adverse":[269],"effects.":[270],"Carefully":[271],"monitored":[272],"trials":[273],"provide":[277],"meaningful":[278],"benefits":[279],"minority":[282],"patients.":[285]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}